1. Home
  2. ILAG vs GNPX Comparison

ILAG vs GNPX Comparison

Compare ILAG & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILAG
  • GNPX
  • Stock Information
  • Founded
  • ILAG 1981
  • GNPX 2009
  • Country
  • ILAG Hong Kong
  • GNPX United States
  • Employees
  • ILAG N/A
  • GNPX N/A
  • Industry
  • ILAG Office Equipment/Supplies/Services
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ILAG Consumer Discretionary
  • GNPX Health Care
  • Exchange
  • ILAG Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • ILAG 10.4M
  • GNPX 10.8M
  • IPO Year
  • ILAG 2022
  • GNPX 2018
  • Fundamental
  • Price
  • ILAG $0.48
  • GNPX $2.82
  • Analyst Decision
  • ILAG
  • GNPX
  • Analyst Count
  • ILAG 0
  • GNPX 0
  • Target Price
  • ILAG N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • ILAG 36.5K
  • GNPX 521.3K
  • Earning Date
  • ILAG 12-19-2025
  • GNPX 11-14-2025
  • Dividend Yield
  • ILAG N/A
  • GNPX N/A
  • EPS Growth
  • ILAG N/A
  • GNPX N/A
  • EPS
  • ILAG N/A
  • GNPX N/A
  • Revenue
  • ILAG $7,506,551.00
  • GNPX N/A
  • Revenue This Year
  • ILAG N/A
  • GNPX N/A
  • Revenue Next Year
  • ILAG N/A
  • GNPX N/A
  • P/E Ratio
  • ILAG N/A
  • GNPX N/A
  • Revenue Growth
  • ILAG 16.50
  • GNPX N/A
  • 52 Week Low
  • ILAG $0.34
  • GNPX $2.77
  • 52 Week High
  • ILAG $1.06
  • GNPX $63.00
  • Technical
  • Relative Strength Index (RSI)
  • ILAG 42.84
  • GNPX 41.66
  • Support Level
  • ILAG $0.42
  • GNPX $7.71
  • Resistance Level
  • ILAG $0.53
  • GNPX $5.00
  • Average True Range (ATR)
  • ILAG 0.06
  • GNPX 0.72
  • MACD
  • ILAG -0.00
  • GNPX -0.38
  • Stochastic Oscillator
  • ILAG 28.01
  • GNPX 1.70

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: